pyrazole has been researched along with benzoxazoles in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fun, HK; Isloor, AM; Shetty, P; Sundershan, S; Vijesh, AM | 1 |
Chae, CH; Cho, SY; Ha, JD; Jung, H; Kim, HR; Lee, BH; Lee, JH; Oh, KS; Seo, HW; Yun, CS | 1 |
Boesen, T; Claesson, HE; Forsell, P; Groth, T; Hallberg, A; Krog-Jensen, C; Kromann, H; Larhed, M; Nilsson, P; No, K; Öhrman, S; Pelcman, B; Sanin, A; Schaal, W; Vogensen, SB | 1 |
Abdelgawad, MA; Bakr, RB; Omar, HA | 1 |
4 other study(ies) available for pyrazole and benzoxazoles
Article | Year |
---|---|
New pyrazole derivatives containing 1,2,4-triazoles and benzoxazoles as potent antimicrobial and analgesic agents.
Topics: Analgesics; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzoxazoles; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Molecular Structure; Pain; Pain Measurement; Pyrazoles; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2013 |
Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors.
Topics: Amines; Benzoxazoles; Binding Sites; Catalytic Domain; Drug Design; Enzyme Activation; G-Protein-Coupled Receptor Kinase 2; G-Protein-Coupled Receptor Kinase 5; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Structure-Activity Relationship | 2013 |
3-Substituted pyrazoles and 4-substituted triazoles as inhibitors of human 15-lipoxygenase-1.
Topics: Arachidonate 15-Lipoxygenase; Benzoxazoles; Humans; Lipoxygenase Inhibitors; Pyrazoles; Structure-Activity Relationship; Triazoles | 2015 |
Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
Topics: Antineoplastic Agents; Benzimidazoles; Benzothiazoles; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Pyrazoles; Structure-Activity Relationship | 2017 |